Man, you guys are really beginning to

New Post Public Reply Private Reply Replies (1) Message Board
picon
Man, you guys are really beginning to suck.

Alternaturals Inc. Announces Exclusive New Products & Marketing Strategy

GRANDVILLE, Mich., Sept. 9, 2014 /PRNewswire via COMTEX/ -- Alternaturals, Inc., (OTCPink: ANAS) announced the release of new solutions to both weight loss and testosterone replacement therapy. Additionally, further details in regards to their affiliate marketing strategies have officially been disclosed.
"The astronomical rate of obesity is unfortunate, but as a business; it's something ANAS can capitalize on. We can't control the world's eating and activity habits but that doesn't mean we can't assist in helping to fight the global weight epidemic in our own way. "Cellurite" is 'that way.' We've composed a propriety formula we're ecstatic about and will be prepared for retail very shortly. I'm extremely proud of the fact that we're able to provide this option to those becoming more health conscious." Says Matthew Briggs, CEO

"Cellurite" will utilize a blend of various proven fat burning natural ingredients such as L-Carnitine, Cayenne Pepper Extract, Green Tea Extract, Alpha Lipoic Acid, and Yohimbine.

Furthermore, ANAS intends on releasing "Priapin." It will utilize the many benefits of D-Aspartic Acid along with a blend of vitamins, herbs and minerals. "All men inevitably experience decreasing testosterone levels with age. Not only does this lead to decreased libido, but also a much bigger issue; energy and focus. We're all still waiting for the discovery of the Fountain of Youth but until then we will keep our male customers placated with "Priapin." Says Matthew Briggs, CEO.

In addition, the ANAS website redesign was finished in record time. The new, more efficient website will allow Chief Technology Officer, Mark Tiarra the ability to accelerate progress towards completion of the affiliate program. "The team has really pulled together to get this ready and I'm proud of the result. I think it conveys the personality of this company and our commitment to providing a real, high quality product. I want our digital face to be as good as our natural one," said Mr. Tiarra, CTO. Mr. Briggs further adds, "Not only has the affiliate program offered ANAS an incredible avenue for revenue, but it's also assisted in product creation. Our large affiliates are currently selling fat loss and testosterone boosting products and requested we release our rendition. Without their suggestion and proven sales history within these niches, we wouldn't have conceived our two latest products. The synergy will be truly incredible."

About Alternaturals, Inc.Alternaturals, Inc. is a manufacturer and distributor of supplements and all-natural remedies that are alternatives to prescription drugs. The company has two popular products, Focamine© and Sombium© and has many proprietary formulas in several natural-remedy related industries that are scheduled for release during the next twelve months. For more information go to www.alternaturals.com, or @alternaturals on twitter.

DISCLAIMERThis Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.

SOURCE Alternaturals, Inc.

Alternaturals, Inc. (ANAS) Stock Research Links

ANAS Board Company Profile Buy Rating Time & Sales News Filings Financials
In times when you feel low self esteem, disappointment and perhaps even depression.......keep in mind that it may simply be the result of the fact that you are surrounded by ass holes. GLTA
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 24

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 33

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 28

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 18

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 37

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 46

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 30

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Gene-Editing Therapy CS-121 Revolutionizes Hyperlipidemia Treatment

Updated Category News Views 232

Transformative Progress in Gene-Editing Therapies CorrectSequence Therapeutics Co., Ltd. is at the forefront of biotechnology innovation with its promising gene-editing therapy, CS-121, designed to tackle chylomicronemia and hypertriglyceridemia. This breakthrough comes as an exciting advancement in the medical field, particularly for patients suffering from severe lipid...

Continue Reading
Blue Ridge Partners Showcases Expertise at PEI Forum Europe

Updated Category News Views 211

Blue Ridge Partners Takes Center Stage at Key Forum Blue Ridge Partners, a leading global management consultancy, will serve as the Knowledge Partner for a significant upcoming event in the private equity sector. The firm is excited to announce its role in the 2025 PEI Operating Partners Forum Europe, taking place in May. Over a decade of collaboration as the Knowledge...

Continue Reading
Alger Russell Innovation Index Q4 2025 Rebalancing Insights

Updated Category News Views 81

Alger Russell Innovation Index Changes for Q4 2025 Fred Alger Management, LLC, a notable growth equity investment manager, has announced significant updates to the Alger Russell Innovation Index. This announcement concerns the quarterly rebalancing that will take place after the trading session concludes. These changes reflect the ever-evolving landscape of investment...

Continue Reading
Partners Value Split Corp. Announces Redemption of Shares

Updated Category News Views 205

Partners Value Split Corp. to Redeem Class AA Preferred Shares Recently, Partners Value Split Corp. (the “Company”) shared exciting news regarding its Class AA Preferred Shares, Series 9. This announcement indicates the Company’s intention to redeem all of its outstanding 5,996,800 Preferred Shares, Series 9 for cash, in accordance with the established terms....

Continue Reading
Pagos' MCP Server: The Future of Payment Data Access?

Updated Category News Views 160

Pagos unveiled a significant upgrade to its Model Context Protocol (MCP) Server on February 17, 2026. This expansion aims to revolutionize how merchants access and analyze their verified payments data directly via AI chat agents like ChatGPT and Claude. Traders in the fintech space are already sizing up this move, pondering whether it marks a genuine leap forward or just...

Continue Reading